RGNX

REGENXBIO Inc
23.75
-0.31 (-1.29%)
Upgrade to Real-Time
Afterhours (Closed)
23.75
Volume 327,093
Bid Price 23.75
Ask Price 25.27
News (1)
Day High 24.28

Low
18.69

52 Week Range

High
35.73

Day Low 23.34
Company Name Stock Ticker Symbol Market Type
REGENXBIO Inc RGNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.31 -1.29% 23.75 20:00:00
Open Price Low Price High Price Close Price Prev Close
23.43 23.34 24.28 23.75 24.06
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,823 327,093 $ 23.88 $ 7,810,248 - 18.69 - 35.73
Last Trade Time Type Quantity Stock Price Currency
17:51:39 10 $ 23.75 USD

Period:

Draw Mode:

REGENXBIO Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.03B 43.29M 28.43M $ 470.35M $ 48.87M 2.91 13.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 1.30%

more financials information »

REGENXBIO News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.0024.3022.1823.38435,9400.753.26%
1 Month22.6225.5421.7323.25343,3021.135.0%
3 Months21.8725.5420.6822.86348,8571.888.6%
6 Months32.8935.7319.8224.73347,949-9.14-27.79%
1 Year25.2535.7318.6925.75383,834-1.50-5.94%
3 Years44.0454.9718.6933.07400,309-20.29-46.07%
5 Years24.3585.1018.6940.94450,108-0.60-2.46%

REGENXBIO Description

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).